We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAGH:NASDAQMagnitude International Ltd Analysis

Data as of 2026-06-11 - not real-time

$6.76

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Magnitude International is trading in a tight range with price stuck at a technical pivot that acts as both support and resistance, while the RSI is deep in overbought territory indicating strong short‑term buying pressure. MACD has turned bearish, the histogram is negative and the signal line suggests further downside, and the beta is negative, implying the stock moves opposite to the broader market. Volatility over the past month is essentially flat, yet the historical maximum drawdown has been severe, highlighting the potential for sharp declines. The company’s fundamentals are weak: profit margins are negative, operating cash flow is deeply negative, and the price‑to‑book multiple is extremely high, suggesting the market is pricing in significant risk. Cash on hand is modest relative to debt, and the equity base is very thin, which raises solvency concerns. Adding to the pressure, a securities‑fraud investigation has been launched, creating regulatory and reputational headwinds.
Given these dynamics, the stock appears overvalued on a value basis, with limited growth prospects and no dividend cushion. The combination of technical bearishness, distressed financials, and legal uncertainty points to a high‑risk profile. Investors should treat any exposure as speculative and be prepared for potential further price erosion. A cautious stance is warranted until the investigation resolves and the company demonstrates a path to positive cash generation.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • bearish MACD signal
  • overbought RSI
  • ongoing fraud investigation

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • potential resolution of legal matters
  • need for cash‑flow turnaround
  • uncertain earnings recovery

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • structural industry exposure
  • possible strategic restructuring
  • absence of dividend support

Key Metrics & Analysis

Financial Health

Revenue Growth-4.50%
Profit Margin-11.07%
ROE-44.15%
ROA-8.35%
Debt/Equity45.12
P/B Ratio51.5
Op. Cash Flow$-4640541
Free Cash Flow$-6800590
Industry P/E29.9

Technical Analysis

TrendNeutral
RSI92.2
Support$6.76
Resistance$6.76
MA 20$6.76
MA 50$6.76
MA 200$5.07
MACDBearish
VolumeStable
Fear & Greed Index81.63

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta-0.76
0
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.